跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GRANISETRON KABI CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
GRANISETRON KABI CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML
Approved
THERAPEUTIC
GRANISETRON KABI CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML
LABESFAL - LABORATÓRIOS ALMIRO S.A. (FRESENIUS KABI GROUP) (PORTUGAL)
🇸🇬 Health Sciences Authority
Approval Date
Sep 23, 2013
Approval ID
7d215bb57695d9d7
Company
LABESFAL - LABORATÓRIOS ALMIRO S.A. (FRESENIUS KABI GROUP) (PORTUGAL)
Type
Therapeutic
Approval Details
Approval Id
7d215bb57695d9d7
Drug Name
GRANISETRON KABI CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML
Product Name
GRANISETRON KABI CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML
Approval Number
SIN14409P
Approval Date
2013-09-23
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
A04A A02
Atc Item Name
xa 04 a a 02
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path
/organization/fresenius-kabi-singapore-pte-ltd
Active Ingredients
Granisetron Hydrochloride 1.12mg/ml eqv Granisetron
1mg/ml
Granisetron Hydrochloride 1.12mg/ml eqv Granisetron
1mg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 23, 2013
Approval ID
7d215bb57695d9d7
Type
Therapeutic
Back to HSA Approvals
